Dimitry Palceski, DO
Procedural Dermatology · Winter Park, FLNPI 1265407290
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,076 of the $23,250 with a category attached, or 73.4%. It is spread thinly across 47 manufacturers, the largest accounting for just 17.4%. Among procedural dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 943 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$4K
- AbbVie$4K
- Biofrontera Inc.$3K
- Almirall LLC$1K
- Sanofi$1K
- UCB, Inc.$957
- plus $9K from 41 others
What the payments were for
- Consulting fees$3,25014%
- Speaking & faculty fees$2,50011%
- Travel & lodging$220%
- Food & beverage$17,07673%
- Education$4022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$2,618
- BF-RhodoLED$2,618
- XEPI$2,618
- Seysara$1,000
- Cimzia$104
How this compares
$23,250 in reported general payments places this provider in the 90th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 17 | $98,100 |
| Doxycycline Hyclate | 41 | $1,491 |
| Clobetasol Propionate | 24 | $703 |
| Mupirocin | 55 | $414 |
| Minoxidil | 20 | $321 |
| Ketoconazole | 20 | $299 |
| ValacyclovirValacyclovir Hcl | 16 | $227 |
| Triamcinolone Acetonide | 29 | $196 |
| Nystatin | 11 | $143 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Winter Park
- Luis SoroFort Lauderdale$307K
- Laertes ManuelidisFort Myers$252K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Samantha MarroneOrlando$22K
- Robert BrownOrange Park$22K
- Ileana Perez-QuintairosSouth Miami$16K
- Lawrence StrongWellington$13K
- Melanie HaynesPinellas Park$9K
- Ronald KnipeOrlando$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.